Bioprosthetic valve failure. Comparative trial of two balloon-expandable transcatheter heart valve systems in intermediate-risk patients: a propensity score analysis.
Guering Eid-LidtSaid Vega ServínJulio Iván Farjat PasosAgustín Rivera RodríguezCarlos A Anaya MoralesLuis Alfonso Marroquin DondayLuis Nombela-FrancoJorge GasparPublished in: Acta cardiologica (2021)
The BVF rate at 25 months of follow-up was similar with the XT and S3 systems. During this follow-up period, the major composite events of death from any cause and neurological events were significantly lower with the S3 system.
Keyphrases
- aortic valve
- mitral valve
- ejection fraction
- aortic stenosis
- end stage renal disease
- newly diagnosed
- aortic valve replacement
- chronic kidney disease
- transcatheter aortic valve replacement
- clinical trial
- prognostic factors
- randomized controlled trial
- left ventricular
- phase iii
- patient reported outcomes
- data analysis